PROCEPT BioRobotics Corporation (PRCT)
Last updated: 2026-10-21 12:05:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
PROCEPT BioRobotics Corporation (PRCT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $18.92, with a market capitalization of $1.05B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.67 to $38.11. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.05B | |
$18.82 | |
$103.81 | |
$15.38 | |
$18.82 | |
734.00 | |
1.42M | |
-- | |
$38.11 | |
$16.67 | |
-- | |
-- |
PROCEPT BioRobotics Corporation (PRCT) Pre-Market Stock Price
PROCEPT BioRobotics Corporation (PRCT) is trading at $18.92 in pre-market trading as of 2026-10-21 11:59:00, up 0.51% ($0.10) from the previous close of $18.82
Pre-market trading shows how investors are pricing PRCT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
PROCEPT BioRobotics Corporation (PRCT) 7-Day Stock Price Change
Over the past seven days, PROCEPT BioRobotics Corporation (PRCT) moved from $19.57 to $18.92, representing a decline of 3.34% ($0.65).
The stock traded between $17.49 and $19.87 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 1.43 million shares, up versus the previous seven-day period, indicating higher trading activity.
PRCT 52-Week Price Position
Position in Range: 10.5%
PRCT is currently trading at $18.92, placing it 10.5% of the way from its 52-week low of $16.67 to its 52-week high of $38.11. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is PROCEPT BioRobotics Corporation (PRCT)?
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
PROCEPT BioRobotics Corporation Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 888 |
| Exchange | NASDAQ |
| Company Website |
How to Buy PROCEPT BioRobotics Corporation (PRCT) Stock on MEXC
Eligible investors can buy real shares of PROCEPT BioRobotics Corporation (PRCT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is PROCEPT BioRobotics Corporation (PRCT) stock price today?
2.Is PRCT stock going up or down today?
3.What is PRCT pre-market price?
4.What is PRCT after-hours price?
5.Is PRCT stock trading now?
6.Where does PRCT sit relative to its 52-week high and low?
7.What sector is PROCEPT BioRobotics Corporation in?
8.What is PROCEPT BioRobotics Corporation's market capitalization and where is it listed?
9.How is PRCT valued in terms of P/E ratio and EPS?
10.Does PROCEPT BioRobotics Corporation pay a dividend?
Explore More US Stocks
Search Stocks
PRCT Stock Calculator
Estimate the value between PRCT shares and USD.
PRCT Shares to USD
1.00 PRCT shares = 18.916 USD
Calculations are estimates based on the latest available price and are for reference only.


